Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zeng, Ping ^a   Chen, Min Bin ^a   Zhou, Li Na ^a   Tang, Min ^a   Liu, Chao Ying ^b   Lu, Pei Hua ^b  

^a JIANGSU UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; TACSTD2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

GENE EXPRESSION; GENETICS; HUMAN; META ANALYSIS; MORTALITY; NEOPLASM; PROGNOSIS; PUBLISHING; SURVIVAL ANALYSIS;

ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CELL ADHESION MOLECULES; GENE EXPRESSION; HUMANS; NEOPLASMS; PROGNOSIS; PUBLICATION BIAS; SURVIVAL ANALYSIS;

EID: 84988452833     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33658     Document Type: Review

References (36)

1. Lipinski, M., Parks, D. R., Rouse, R. V., Herzenberg, L. A. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America 78, 5147-5150 (1981).
2. Fornaro, M. et al. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. International journal of cancer 62, 610-618 (1995).
3. Ripani, E., Sacchetti, A., Corda, D., Alberti, S. Human Trop-2 is a tumor-associated calcium signal transducer. International journal of cancer 76, 671-676 (1998).
4. Cubas, R., Li, M., Chen, C., Yao, Q. Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochimica et biophysica acta 1796, 309-314 (2009).
5. Trerotola, M. et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 32, 222-233 (2013).
6. Goldstein, A. S. et al. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proceedings of the National Academy of Sciences of the United States of America 105, 20882-20887 (2008).
7. Okabe, M. et al. Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development (Cambridge, England) 136, 1951-1960 (2009).
8. Cubas, R., Zhang, S., Li, M., Chen, C., Yao, Q. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Molecular cancer 9, 253 (2010).
9. Pak, M. G., Shin, D. H., Lee, C. H., Lee, M. K. Significance of EpCAM and TROP2 expression in non-small cell lung cancer. World journal of surgical oncology 10, 53 (2012).
10. Li, Z., Jiang, X., Zhang, W. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells. Biochemical and biophysical research communications 470, 197-204 (2016).
11. Chen, R. et al. Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal type. Virchows Archiv: an international journal of pathology 463, 713-719 (2013).
12. Trerotola, M. et al. Trop-2 promotes prostate cancer metastasis by modulating beta(1) integrin functions. Cancer research 73, 3155-3167 (2013).
13. Ning, S. et al. TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 34, 1745-1750 (2013).
14. Muhlmann, G. et al. TROP2 expression as prognostic marker for gastric carcinoma. Journal of clinical pathology 62, 152-158 (2009).
15. Zhao, W. et al. Trop2 is overexpressed in gastric cancer and predicts poor prognosis. Oncotarget 7, 6136-6145 (2016).
16. Guan, G. F. et al. Prognostic value of TROP2 in human nasopharyngeal carcinoma. International journal of clinical and experimental pathology 8, 10995-11004 (2015).
17. Chen, M. B. et al. Prognostic value of TROP2 expression in patients with gallbladder cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 35, 11565-11569 (2014).
18. Liu, T. et al. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PloS One 8, e75864 (2013).
19. Kobayashi, H. et al. Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma. Virchows Archiv: an international journal of pathology 457, 69-76 (2010).
20. Wu, H. et al. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma. Head & neck 35, 1373-1378 (2013).
21. Ohmachi, T. et al. Clinical significance of TROP2 expression in colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 12, 3057-3063 (2006).
22. Fang, Y. J. et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. International journal of colorectal disease 24, 875-884 (2009).
23. Xu, K. Y., Gu, J. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 12, 285-289 (2009).
24. Ning, S. et al. TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract 17, 360-368 (2013).
25. Fong, D. et al. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. British journal of cancer 99, 1290-1295 (2008).
26. Fong, D. et al. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 21, 186-191 (2008).
27. Bignotti, E. et al. Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma. BMC clinical pathology 12, 22 (2012).
28. Bignotti, E. et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. European journal of cancer 46, 944-953 (2010).
29. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. International journal of surgery 8, 336-341 (2010).
30. Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., Sydes, M. R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8, 16 (2007).
31. Higgins, J. P., Thompson, S. G., Deeks, J. J., Altman, D. G. Measuring inconsistency in meta-analyses. Bmj 327, 557-560 (2003).
32. DerSimonian, R., Laird, N. Meta-analysis in clinical trials. Controlled clinical trials 7, 177-188 (1986).
33. Egger, M., Davey Smith, G., Schneider, M., Minder, C. Bias in meta-analysis detected by a simple, graphical test. Bmj 315, 629-634 (1997).
34. Duval, S., Tweedie, R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 56, 455-463 (2000).
35. Yang, J. et al. Trop2 regulates the proliferation and differentiation of murine compact-bone derived MSCs. International journal of oncology 43, 859-867 (2013).
36. Ambrogi, F. et al. Trop-2 is a determinant of breast cancer survival. PloS one 9, e96993 (2014).